Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are widely used in general clinical practice to measure liver injury and have been proved to be associated with metabolic diseases, cardiovascular diseases (12), non-alcoholic fatty liver disease (NAFLD) (13), and upper tract urothelial cancer (14). The gene discussed is GPT; the disease is cardiovascular disorder.